« Return to News | CROs/Service Providers

SFBC Exits Florida

Thursday, May 18, 2006 02:34 PM

It should comes as no surprise that SFBC is getting out of Florida after its Miami phase I unit performed so poorly last quarter.  Current SFBC officials—the former heads of PharmaNet—needed to stop the bleeding before the whole company was in jeopardy. Its later phase business is still holding its own.

SFBC International decided May 17 to end its early phase business in Florida after county officials wouldn't extend a review of some planned renovations to its troubled Miami phase I unit. The phase I unit has been the subject of numerous stories detailing serious issues with structural safety and questionable recruitment of undocumented workers as trial participants.

SFBC, which earlier this year moved its headquarters to PharmaNet’s HQ in Princeton, N.J., said that its Florida operations, including Ft. Myers, were expected to account for 10% of 2006 revenue. The company also withdrew its financial guidance for 2006.

SFBC officials said they will continue to offer early phase clinical development along with late phase. Now they should get around to a complete transformation by renaming the company PharmaNet.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.